US20040028557A1 - Multi-layer reagent test strip - Google Patents

Multi-layer reagent test strip Download PDF

Info

Publication number
US20040028557A1
US20040028557A1 US10/426,458 US42645803A US2004028557A1 US 20040028557 A1 US20040028557 A1 US 20040028557A1 US 42645803 A US42645803 A US 42645803A US 2004028557 A1 US2004028557 A1 US 2004028557A1
Authority
US
United States
Prior art keywords
test strip
mesh
sample
support
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/426,458
Inventor
Koon-Wah Leong
Yeung Yu
Edward Rice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
LifeScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeScan Inc filed Critical LifeScan Inc
Priority to US10/426,458 priority Critical patent/US20040028557A1/en
Assigned to LIFESCAN, INC. reassignment LIFESCAN, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LEONG, KOON-WAH, RICE, EDWARD GRAY, YU, YEUNG SIU
Publication of US20040028557A1 publication Critical patent/US20040028557A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525—Multi-layer analytical elements
    • G01N33/526—Multi-layer analytical elements the element being adapted for a specific analyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Definitions

  • This invention relates to a dry test strip for measuring the concentration of an analyte in a biological fluid; more particularly, a test strip that calorimetrically measures the concentration of glucose in whole blood.
  • Many visual test devices have been developed for measuring the concentration of certain analytes in biological fluids. These devices have, for example, measured glucose, cholesterol, proteins, ketones, phenylalanine, or enzymes in blood, urine, or saliva.
  • Reagent strips that are used in these devices contain an indicator that turns a different shade and/or intensity of color, depending on the concentration of glucose in the blood sample that has been applied to the strip. Although some of these strips use reduction chemistries, more commonly they involve an oxidizable dye or dye couple. Some of the strips include an enzyme, such as glucose oxidase, which is capable of oxidizing glucose to gluconic acid and hydrogen peroxide. They also contain an oxidizable dye and a substance having peroxidative activity, which is capable of selectively catalyzing oxidation of the oxidizable dye in the presence of hydrogen peroxide.
  • an enzyme such as glucose oxidase, which is capable of oxidizing glucose to gluconic acid and hydrogen peroxide. They also contain an oxidizable dye and a substance having peroxidative activity, which is capable of selectively catalyzing oxidation of the oxidizable dye in the presence of hydrogen peroxide.
  • U.S. Pat. No. 4,292,272, issued Sep. 29, 1981 to M. Kitajima et al. discloses a multilayer strip for analysis that comprises a light-transmitting support, a reagent layer and a spreading layer, laminated together and to the support.
  • the spreading layer is hydrophilic and supplies a liquid sample applied on its surface at a substantially constant volume per unit area to the reagent layer.
  • U.S. Pat. No. 4,631,174 issued Dec. 23, 1986 to A. Kondo, discloses a multilayer chemical analysis member that includes, superposed and bonded together, a support, a reagent layer, a porous spreading layer, and a waterproof layer.
  • the waterproof layer has a small opening for applying a drop of sample. The sample diffuses through the spreading layer and into the reagent layer, where a color develops, as discussed above.
  • the purpose of the waterproof layer is to retard evaporation of the sample, which “invariably” spreads outward laterally in the spreading layer, beyond the opening in the waterproof layer. Thereby, the “major portion of fragile spreading layer is protected by the waterproof layer.”
  • U.S. Pat. No. 4,935,346, issued Jun. 19, 1990 to R. Phillips et al. discloses a meter, strip, and method for determining the glucose concentration in a sample of whole blood (see also U.S. Pat. No. 5,304,468).
  • the method involves simply applying a sample of whole blood to a first (“sample”) surface of an inert porous matrix that is impregnated with a reagent.
  • the sample migrates toward the opposite, “testing,” surface, as the glucose interacts with the reagent to produce a light-absorbing reaction product.
  • a reading of reflectance from the testing surface indicates the glucose concentration.
  • Reflectance measurements are made at two separate wavelengths in order to eliminate interferences.
  • a timing circuit is triggered by an initial decrease in reflectance caused by wetting of the testing surface by the sample having passed through the matrix.
  • U.S. Pat. No. 5,200,148 issued Apr. 6, 1993 to Y. Saito, discloses a chemical assay tape that includes a support layer and at least one porous spreading layer.
  • a reagent layer (and, optionally, a filter layer) may be sandwiched between the spreading layer and the support or, alternatively, the reagent may be incorporated into the spreading layer. Grooves cut into the spreading layer prevent cracking when the tape is wound.
  • U.S. Pat. No. 5,215,712 issued Jun. 1, 1993 to T. Kawanishi et al., discloses an apparatus and method for determining ion concentration, specific gravity, or osmotic pressure of a solution.
  • An apparatus of the invention may contain a support having an opening that is covered with a transparent film, which, together with a reagent layer, sandwiches a spreading layer.
  • the support layer is also provided with a retaining part.
  • U.S. Pat. No. 5,296,192 issued Mar. 22, 1994 to P. Carroll et al., discloses a diagnostic test strip for whole blood that has two support layers, between which are a spreading screen, a separating layer (to remove red blood cells), and a reagent layer.
  • U.S. Pat. No. 5,709,837 issued on Jan. 20, 1998 to T. Mori et al., discloses a dry analytical element that includes a support, a reagent layer on the support, and a porous, spreading layer on the reagent layer.
  • An adhesive layer may be on the regent layer to join the spreading layer.
  • U.S. Pat. No. 5,968,836, issued on Oct. 19, 1999 to D. Matzinger et al. discloses a reagent strip that has a testing pad sandwiched between a support and a transport medium. A fluid sample is applied to the transport medium and travels through it to the testing pad, in which a reagent reacts with an analyte of interest that is present in the sample to cause a color change.
  • the support has an aperture, through which the color change in the testing pad can be viewed.
  • a meter that has come into widespread use for self-monitoring of blood glucose is the One Touch® Profile meter, which uses a strip that is described, inter alia, in U.S. Pat. Nos. 4,935,346 and 5,304,468, discussed above.
  • the meter and strip permit a user to measure glucose concentration in a whole blood sample quickly, easily, and accurately.
  • the sample is applied to one surface of the strip and the measurement made on the opposite surface. A portion of the whole blood sample penetrates from the sample surface to the testing surface, and the blood color can be observed from the testing surface.
  • the present invention provides a reagent test Strip for use in an apparatus for determining an analyte concentration in a sample of biological fluid.
  • the apparatus comprises optical means for detecting intensity of light reflected from a surface of the strip.
  • the strip comprises
  • a reagent test strip of this invention is used 11 an apparatus that comprises optical means for detecting intensity of light at wavelengths of about 635 nm and about 700 nm reflected from at least a portion of the testing surface of the strip.
  • the invention provides a reagent test strip that is suitable for use in a One Touch® Profile whole blood glucose meter (or similar One Touch meter). Since the strip includes a mesh, which spreads the sample laterally, before the sample enters the matrix, it permits a glucose determination to be made using a smaller whole blood sample than is needed for a strip that lacks the mesh.
  • FIG. 1 is a perspective view of an embodiment of a test strip of this invention.
  • FIG. 2 is a cross section through A-A of the strip of FIG. 1.
  • the test strip of the present invention provides a user an opportunity to obtain accurate determinations of analyte concentration, using a smaller sample size than heretofore.
  • the sample is whole blood, as is the case when the strip is used for self monitoring of blood glucose (SMBG), then the ability to use a smaller sample size is an important advantage.
  • SMBG blood glucose
  • FIG. 1 is a perspective view of a strip 10 of the present invention, and FIG. 2 depicts a cross section through A-A.
  • Mesh 12 is sandwiched between support layer 14 and matrix layer 16 .
  • Optional adhesive 18 attaches mesh 12 and, optionally, matrix 16 to support 14 .
  • Sample inlet 20 is a hole through support layer 14 , which is preferably a thermoplastic.
  • a blood sample is applied to mesh 12 through the sample inlet 20 .
  • the sample penetrates through mesh 12 spreads out to uniformly cover sample-receiving surface 22 of matrix layer 16 .
  • the mesh does not appreciably absorb any sample.
  • adhesive 18 it limits the perimeter of gap 24 and, consequently, the extent to which sample is spread by capillary action.
  • mesh 12 is of a hydrophilic material, woven or non-woven. More preferably, the mesh surface has been modified by, for example, a surfactant coating, plasma treatment, or other well-known process. Polyester or polyamide filament is suitable. Alternatively, the mesh could be of another organic or inorganic material, or metallic, or a combination of more than one of these. The mesh has an open area that is preferably more than 50%.
  • a suitable mesh is available from Sefar America Inc., Depew, N.Y. The mesh is designated as product code RMS 075 and its characteristics are: material monofilament polyester fiber diameter 0.025 mm mesh thickness 0.05 mm % open area 75 weave type square (plain)
  • the large open area permits the matrix layer to be adhered to the support layer through the mesh, the requirement being that the adhesive layer have a thickness at least about the same as the mesh thickness.
  • the mesh has a surfactant coating that expedites the spread of sample over the matrix layer.
  • the spreading is further enhanced by capillary gap 24 formed between the mesh and matrix layer. The improvement in spreading is particularly pronounced for samples that have high viscosity (e.g., high hematocrit samples).
  • the matrix layer is preferably a polyamide membrane that contains a reagent that reacts with glucose in the blood sample to provide a color change that can be related to the glucose concentration in the sample.
  • a suitable reagent comprises glucose oxidase, horseradish peroxidase, and the dye precursor 3-methyl-2 benzothiazolinone hydrazone hydrochloride and 3-dimethylaminobenzoic acid. Additional details concerning suitable membrane and reagent compositions appear in U.S. Pat. No. 5,304,468, issued Apr. 19. 1994, to Phillips et al., incorporated herein by reference.

Abstract

A reagent test strip for measuring an analyte concentration in a biological fluid has a spreading mesh sandwiched between a support and a reagent matrix. The support has a through hole that is covered by the mesh. In use, a sample of the fluid is applied through the hole in the support to the spreading mesh. The sample then passes through the mesh to the matrix, which contains a reagent that indicates the analyte concentration by causing a corresponding change in reflectance at its free surface. Optionally, an adhesive layer attaches the mesh, and optionally the matrix as well, to the support.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0001]
  • This invention relates to a dry test strip for measuring the concentration of an analyte in a biological fluid; more particularly, a test strip that calorimetrically measures the concentration of glucose in whole blood. [0002]
  • 2. Description of the Related Art [0003]
  • Many visual test devices have been developed for measuring the concentration of certain analytes in biological fluids. These devices have, for example, measured glucose, cholesterol, proteins, ketones, phenylalanine, or enzymes in blood, urine, or saliva. [0004]
  • Among the devices that are in most widespread use today is the blood glucose monitor. In the U.S. alone, there are estimated to be about 16 million people with diabetes. In order to avoid serious medical problems, such as vision loss, circulatory problems, kidney failure, etc., many of these people monitor their blood glucose on a regular basis and then take the steps necessary to maintain their glucose concentration in an acceptable range. [0005]
  • Reagent strips that are used in these devices contain an indicator that turns a different shade and/or intensity of color, depending on the concentration of glucose in the blood sample that has been applied to the strip. Although some of these strips use reduction chemistries, more commonly they involve an oxidizable dye or dye couple. Some of the strips include an enzyme, such as glucose oxidase, which is capable of oxidizing glucose to gluconic acid and hydrogen peroxide. They also contain an oxidizable dye and a substance having peroxidative activity, which is capable of selectively catalyzing oxidation of the oxidizable dye in the presence of hydrogen peroxide. [0006]
  • U.S. Pat. No. 4,292,272, issued Sep. 29, 1981 to M. Kitajima et al. discloses a multilayer strip for analysis that comprises a light-transmitting support, a reagent layer and a spreading layer, laminated together and to the support. The spreading layer is hydrophilic and supplies a liquid sample applied on its surface at a substantially constant volume per unit area to the reagent layer. [0007]
  • U.S. Pat. No. 4,631,174, issued Dec. 23, 1986 to A. Kondo, discloses a multilayer chemical analysis member that includes, superposed and bonded together, a support, a reagent layer, a porous spreading layer, and a waterproof layer. The waterproof layer has a small opening for applying a drop of sample. The sample diffuses through the spreading layer and into the reagent layer, where a color develops, as discussed above. The purpose of the waterproof layer is to retard evaporation of the sample, which “invariably” spreads outward laterally in the spreading layer, beyond the opening in the waterproof layer. Thereby, the “major portion of fragile spreading layer is protected by the waterproof layer.”[0008]
  • U.S. Pat. No. 4,935,346, issued Jun. 19, 1990 to R. Phillips et al., discloses a meter, strip, and method for determining the glucose concentration in a sample of whole blood (see also U.S. Pat. No. 5,304,468). The method involves simply applying a sample of whole blood to a first (“sample”) surface of an inert porous matrix that is impregnated with a reagent. The sample migrates toward the opposite, “testing,” surface, as the glucose interacts with the reagent to produce a light-absorbing reaction product. A reading of reflectance from the testing surface indicates the glucose concentration. Reflectance measurements are made at two separate wavelengths in order to eliminate interferences. A timing circuit is triggered by an initial decrease in reflectance caused by wetting of the testing surface by the sample having passed through the matrix. [0009]
  • U.S. Pat. No. 5,200,148, issued Apr. 6, 1993 to Y. Saito, discloses a chemical assay tape that includes a support layer and at least one porous spreading layer. A reagent layer (and, optionally, a filter layer) may be sandwiched between the spreading layer and the support or, alternatively, the reagent may be incorporated into the spreading layer. Grooves cut into the spreading layer prevent cracking when the tape is wound. [0010]
  • U.S. Pat. No. 5,215,712, issued Jun. 1, 1993 to T. Kawanishi et al., discloses an apparatus and method for determining ion concentration, specific gravity, or osmotic pressure of a solution. An apparatus of the invention may contain a support having an opening that is covered with a transparent film, which, together with a reagent layer, sandwiches a spreading layer. The support layer is also provided with a retaining part. [0011]
  • U.S. Pat. No. 5,296,192, issued Mar. 22, 1994 to P. Carroll et al., discloses a diagnostic test strip for whole blood that has two support layers, between which are a spreading screen, a separating layer (to remove red blood cells), and a reagent layer. [0012]
  • U.S. Pat. No. 5,310,525, issued May 10, 1994 to S. Churchouse et al., discloses a fluid detection device that includes an impervious container having a fluid entry aperture and contiguous reagent and spreading layers. The device detects an analyte in a fluid that enters the container and spreads within the spreading layer. The analyte then initiates a reaction in the reagent layer to generate a signal. [0013]
  • U.S. Pat. No. 5,709,837, issued on Jan. 20, 1998 to T. Mori et al., discloses a dry analytical element that includes a support, a reagent layer on the support, and a porous, spreading layer on the reagent layer. An adhesive layer may be on the regent layer to join the spreading layer. [0014]
  • U.S. Pat. No. 5,968,836, issued on Oct. 19, 1999 to D. Matzinger et al., discloses a reagent strip that has a testing pad sandwiched between a support and a transport medium. A fluid sample is applied to the transport medium and travels through it to the testing pad, in which a reagent reacts with an analyte of interest that is present in the sample to cause a color change. The support has an aperture, through which the color change in the testing pad can be viewed. [0015]
  • A meter that has come into widespread use for self-monitoring of blood glucose is the One Touch® Profile meter, which uses a strip that is described, inter alia, in U.S. Pat. Nos. 4,935,346 and 5,304,468, discussed above. The meter and strip permit a user to measure glucose concentration in a whole blood sample quickly, easily, and accurately. The sample is applied to one surface of the strip and the measurement made on the opposite surface. A portion of the whole blood sample penetrates from the sample surface to the testing surface, and the blood color can be observed from the testing surface. [0016]
    • SUMMARY OF THE INVENTION
  • The present invention provides a reagent test Strip for use in an apparatus for determining an analyte concentration in a sample of biological fluid. The apparatus comprises optical means for detecting intensity of light reflected from a surface of the strip. The strip comprises [0017]
  • (a) a support having a through hole for passing a sample of the biological fluid, [0018]
  • (b) a mesh, having a first surface adjoining, and covering the hole in, the support, and [0019]
  • (c) a reagent matrix adjoining a second surface of the mesh, opposite the first surface, the matrix comprising [0020]
  • (i) a sample receiving surface for receiving the sample from the mesh and passing at least a portion of the sample toward a testing surface opposite to the receiving surface and [0021]
  • (ii) a reagent for indicating the analyte concentration, by creating at the testing surface a change in reflectance that can be related to the analyte concentration. [0022]
  • One embodiment of a reagent test strip of this invention is used [0023] 11 an apparatus that comprises optical means for detecting intensity of light at wavelengths of about 635 nm and about 700 nm reflected from at least a portion of the testing surface of the strip. In that embodiment, the invention provides a reagent test strip that is suitable for use in a One Touch® Profile whole blood glucose meter (or similar One Touch meter). Since the strip includes a mesh, which spreads the sample laterally, before the sample enters the matrix, it permits a glucose determination to be made using a smaller whole blood sample than is needed for a strip that lacks the mesh.
    •  BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of an embodiment of a test strip of this invention. [0024]
  • FIG. 2 is a cross section through A-A of the strip of FIG. 1. [0025]
    • DETAILED DESCRIPTION OF THE INVENTION
  • The test strip of the present invention provides a user an opportunity to obtain accurate determinations of analyte concentration, using a smaller sample size than heretofore. When the sample is whole blood, as is the case when the strip is used for self monitoring of blood glucose (SMBG), then the ability to use a smaller sample size is an important advantage. [0026]
  • For brevity and simplicity, the description below will focus on strips for SMBG, but it is clear that the strip of this invention is also suitable for measurements of other analyte concentrations in blood or other sample fluids. [0027]
  • FIG. 1 is a perspective view of a [0028] strip 10 of the present invention, and FIG. 2 depicts a cross section through A-A. Mesh 12 is sandwiched between support layer 14 and matrix layer 16. Optional adhesive 18 attaches mesh 12 and, optionally, matrix 16 to support 14. Sample inlet 20 is a hole through support layer 14, which is preferably a thermoplastic. In use, a blood sample is applied to mesh 12 through the sample inlet 20. The sample penetrates through mesh 12 spreads out to uniformly cover sample-receiving surface 22 of matrix layer 16. Preferably, the mesh does not appreciably absorb any sample. When adhesive 18 is present, it limits the perimeter of gap 24 and, consequently, the extent to which sample is spread by capillary action.
  • Preferably, [0029] mesh 12 is of a hydrophilic material, woven or non-woven. More preferably, the mesh surface has been modified by, for example, a surfactant coating, plasma treatment, or other well-known process. Polyester or polyamide filament is suitable. Alternatively, the mesh could be of another organic or inorganic material, or metallic, or a combination of more than one of these. The mesh has an open area that is preferably more than 50%. A suitable mesh is available from Sefar America Inc., Depew, N.Y. The mesh is designated as product code RMS 075 and its characteristics are:
    material monofilament polyester
    fiber diameter 0.025 mm
    mesh thickness  0.05 mm
    % open area 75
    weave type square (plain)
  • The large open area permits the matrix layer to be adhered to the support layer through the mesh, the requirement being that the adhesive layer have a thickness at least about the same as the mesh thickness. The mesh has a surfactant coating that expedites the spread of sample over the matrix layer. The spreading is further enhanced by [0030] capillary gap 24 formed between the mesh and matrix layer. The improvement in spreading is particularly pronounced for samples that have high viscosity (e.g., high hematocrit samples).
  • Since users of the strip may have impaired vision, [0031] mesh 12 and the top surface of support 14 (seen in FIG. 1) preferably provide high visual contrast (i.e. if the support surface is light, the mesh is dark, or inversely). More preferably, the mesh is brightly colored or fluorescent in ambient visible illumination, so that the mesh is readily visible in typical ambient lighting. The mesh may be colored by any of a variety of techniques, all of which are well known. Among suitable techniques are using colored filament to prepare the mesh, dying the mesh, etc. It is only the part of the mesh that is visible to the user (typically the front surface) that must be colored to provide this advantage.
  • [0032] Optional adhesive 18 is preferably hydrophobic. A pressure-sensitive adhesive available from 3M, St. Paul, Minn.—product code 415—is an example of a suitable adhesive. Preferably, the adhesive encloses the area over which the sample is to spread. It is convenient, but not essential, to have that area correspond to the area of sample inlet 20. By appropriately choosing the area over which the sample can spread, one can design a strip of this invention to permit a test to be made with a minimum sample volume. If sample inlet 20 is to be coextensive with the area surrounded by adhesive 18, the strip can be made by applying adhesive to support layer 14, then punching a hole into the support and adhesive layers, before laminating mesh 12 and matrix layer 16 to the adhesive-coated support.
  • The matrix layer is preferably a polyamide membrane that contains a reagent that reacts with glucose in the blood sample to provide a color change that can be related to the glucose concentration in the sample. A suitable reagent comprises glucose oxidase, horseradish peroxidase, and the dye precursor 3-methyl-2 benzothiazolinone hydrazone hydrochloride and 3-dimethylaminobenzoic acid. Additional details concerning suitable membrane and reagent compositions appear in U.S. Pat. No. 5,304,468, issued Apr. 19. 1994, to Phillips et al., incorporated herein by reference. [0033]
  • An anisotropic membrane is also suitable for use as the matrix of the present invention. When such a membrane is used, the larger pores are near the receiving surface and smaller pores near the testing surface. The anisotropic membrane contains a reagent that includes a dye precursor (chromogen) that forms a chromophore indicative of the glucose concentration in the sample. The concentration is determined from the change in reflectance from the testing surface. Red blood cells, which can interfere with the reflectance readings, are trapped in pores near the receiving surface and don't penetrate to the testing surface. A preferred reagent for use with the anisotropic membrane comprises enzymes to produce an oxidizing agent that indicates glucose concentration by oxidizing a dye precursor that is preferably meta [3-methyl 2-benzothiazolinone hydrazone] N-sulfonyl benzenesulfonate monosodium and 8-anilino-1-naphthalene sulfonic acid. Additional details concerning suitable anisotropic membranes and reagent compositions for use with them appear in U.S. Pat. Nos. 5,563,031 and 5,922,530, issued Oct. 8, 1996 and Jul. 13, 1999, respectively, to Y. S. Yu, incorporated herein by reference. [0034]

Claims (20)

We claim:
1. A reagent test strip for use in an apparatus for measuring an analyte concentration in a biological fluid, comprising
(a) a support having a top surface, a bottom surface opposite, and a through hole for passing a sample of the biological fluid,
(b) a mesh, having a first surface adjoining the bottom surface of and covering the hole in, the support, and
(c) a reagent matrix adjoining a second surface of the mesh, opposite the first surface, the matrix comprising
(i) a sample receiving surface for receiving the sample from the mesh and passing at least a portion of the sample toward a testing surface opposite to the receiving surface and
(ii) a reagent for indicating the analyte concentration, by creating at the testing surface a change in reflectance that can be related to the analyte concentration.
2. The test strip of claim 1, in which the analyte is glucose and the biological fluid is blood.
3. The test strip of claim 1, in which the support comprises a thermoplastic sheet.
4. The test strip of claim 1, in which the top surface of the support and the mesh provide high visual contrast.
5. The test strip of claim 1, in which the mesh is brightly colored or fluorescent.
6. The test strip of claim 1, in which the mesh is hydrophilic.
7. The test strip of claim 1, in which the mesh is substantially non-absorbing of the biological fluid.
8. The test strip of claim 1, in which the mesh comprises polyester or polyamide filament.
9. The test strip of claim 1, in which the mesh has an open area that exceeds 50% of its total area.
10. The test strip of claim 1, in which the mesh is attached to the support with a pressure-sensitive adhesive.
11. The test strip of claim 10, in which the adhesive is not present where the mesh covers the hole.
12. The test strip of claim 10, in which at least a part of the adhesive extends through the mesh and attaches the matrix to the support.
13. The test strip of claim 10, in which the adhesive is hydrophobic.
14. The test strip of claim 1, in which the matrix comprises a polyamide membrane.
15. The test strip of claim 1, in which the matrix is an anisotropic membrane, with larger pores near the sample receiving surface and smaller pores near the testing surface.
16. The test strip of claim 2 in which the reagent comprises a dye precursor that forms a chromophore indicative of the glucose concentration.
17. The test strip of claim 16, in which the dye precursor comprises 3-methyl-2-benzothiazolinone hydrazone hydrochloride and dimethylaminobenzoic acid.
18. The test strip of claim 16, in which the dye precursor comprises meta [3-methyl 2-benzothiazolinone hydrazone] N-sulfonyl benzenesulfonate monosodium and 8-anilino-1-naphthalene sulfonic acid.
19. The test strip of claim 17, in which the matrix comprises a polyamide membrane.
20. The test strip of claim 18, in which the matrix comprises an anisotropic membrane with larger pores near the receiving surface and smaller pores near the testing surface.
US10/426,458 2000-10-05 2003-04-29 Multi-layer reagent test strip Abandoned US20040028557A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/426,458 US20040028557A1 (en) 2000-10-05 2003-04-29 Multi-layer reagent test strip

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/684,716 US6555061B1 (en) 2000-10-05 2000-10-05 Multi-layer reagent test strip
US10/426,458 US20040028557A1 (en) 2000-10-05 2003-04-29 Multi-layer reagent test strip

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/684,716 Continuation US6555061B1 (en) 2000-10-05 2000-10-05 Multi-layer reagent test strip

Publications (1)

Publication Number Publication Date
US20040028557A1 true US20040028557A1 (en) 2004-02-12

Family

ID=24749257

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/684,716 Expired - Lifetime US6555061B1 (en) 2000-10-05 2000-10-05 Multi-layer reagent test strip
US10/426,458 Abandoned US20040028557A1 (en) 2000-10-05 2003-04-29 Multi-layer reagent test strip

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/684,716 Expired - Lifetime US6555061B1 (en) 2000-10-05 2000-10-05 Multi-layer reagent test strip

Country Status (3)

Country Link
US (2) US6555061B1 (en)
MY (1) MY134148A (en)
TW (1) TWM263498U (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858884B2 (en) 2013-03-15 2014-10-14 American Sterilizer Company Coupled enzyme-based method for electronic monitoring of biological indicator
US9121050B2 (en) 2013-03-15 2015-09-01 American Sterilizer Company Non-enzyme based detection method for electronic monitoring of biological indicator
WO2020137532A1 (en) * 2018-12-28 2020-07-02 テルモ株式会社 Test strip and component measurement system

Families Citing this family (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3394262B2 (en) * 1997-02-06 2003-04-07 セラセンス、インク． Small volume in vitro analyte sensor
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US20050103624A1 (en) 1999-10-04 2005-05-19 Bhullar Raghbir S. Biosensor and method of making
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
ES2357887T3 (en) 2001-06-12 2011-05-03 Pelikan Technologies Inc. APPARATUS FOR IMPROVING THE BLOOD OBTAINING SUCCESS RATE FROM A CAPILLARY PUNCTURE.
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
AU2002348683A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
EP1404232B1 (en) 2001-06-12 2009-12-02 Pelikan Technologies Inc. Blood sampling apparatus and method
WO2002100460A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Electric lancet actuator
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
CN100512910C (en) * 2001-09-24 2009-07-15 福永敦翁福 Breathing circuits having unconventional respiratory conduits and systems and methods for optimizing utilization of fresh gases
DE60237463D1 (en) * 2001-11-16 2010-10-07 Roche Diagnostics Gmbh FLEXIBLE SENSOR AND MANUFACTURING PROCESS
US6723500B2 (en) * 2001-12-05 2004-04-20 Lifescan, Inc. Test strips having reaction zones and channels defined by a thermally transferred hydrophobic barrier
US7004928B2 (en) * 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7708701B2 (en) 2002-04-19 2010-05-04 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7052652B2 (en) * 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
EP1625386B8 (en) * 2003-03-24 2021-07-28 Intuity Medical, Inc. Analyte concentration detection devices and methods
CA2522290A1 (en) * 2003-04-15 2004-10-28 Metgen, Inc. Medical device for monitoring blood phenylalanine levels
ES2347248T3 (en) 2003-05-30 2010-10-27 Pelikan Technologies Inc. PROCEDURE AND APPLIANCE FOR FLUID INJECTION.
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8679853B2 (en) 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US8071030B2 (en) * 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
PL1639354T3 (en) 2003-06-20 2018-11-30 F.Hoffmann-La Roche Ag Test strip with slot vent opening
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
WO2005033659A2 (en) 2003-09-29 2005-04-14 Pelikan Technologies, Inc. Method and apparatus for an improved sample capture device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005078118A1 (en) 2004-02-06 2005-08-25 Bayer Healthcare Llc Oxidizable species as an internal reference for biosensors and method of use
DE102004013699A1 (en) * 2004-03-18 2005-10-06 Tesa Ag Pressure-sensitive adhesive tape for medical diagnostic strips
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
NZ588190A (en) * 2004-06-09 2012-04-27 Pathogen Removal & Diagnostic Technologies Inc Separating prion proteins with polyglycidyl methacrylate surface modified matrix
US7569126B2 (en) 2004-06-18 2009-08-04 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US8057740B2 (en) * 2004-06-23 2011-11-15 Tesa Se Medical biosensor by means of which biological liquids are analyzed
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
WO2007013915A1 (en) 2005-07-20 2007-02-01 Bayer Healthcare Llc Gated amperometry
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
CN101273266B (en) 2005-09-30 2012-08-22 拜尔健康护理有限责任公司 Gated voltammetry
JP5147702B2 (en) 2005-09-30 2013-02-20 インテュイティ メディカル インコーポレイテッド Fully integrated wearable or handheld monitor
DE102006032667A1 (en) * 2006-07-13 2008-01-17 Tesa Ag Web-shaped material with a coating that allows a very fast spreading or a very fast transport of liquids
US20080124693A1 (en) * 2006-10-26 2008-05-29 Mcevoy Mary System for determining an analyte in a bodily fluid sample that includes a graphics-based step-by-step tutorial module
US20080101987A1 (en) * 2006-10-31 2008-05-01 Selwayan Saini Analytical test strip with electroluminescent lamp
US7740801B2 (en) * 2006-10-31 2010-06-22 Lifescan Scotland Limited System for determination of an analyte in a bodily fluid sample that includes an electroluminescent component
US20080100689A1 (en) * 2006-10-31 2008-05-01 Selwayan Saini Method for manufacturing an analytical test strip with an electroluminescent component
EP1918708A3 (en) 2006-10-31 2009-12-30 Lifescan Scotland Ltd Analytical test strip with electroluminescent lamp
US20080101984A1 (en) * 2006-10-31 2008-05-01 Selwayan Saini Method for determining an analyte in a bodily fluid sample
US20080101986A1 (en) * 2006-10-31 2008-05-01 Selwayan Saini Analytical test strip with electroluminescent module
EP1918707A3 (en) 2006-10-31 2010-01-06 Lifescan Scotland Limited Analytical test strip with electroluminescent module
DE102007003755A1 (en) 2007-01-19 2008-07-31 Tesa Ag Web-shaped material with a coating that enables a permanent fast spreading or a permanent, very fast transport of liquids
DE102007018383A1 (en) * 2007-04-17 2008-10-23 Tesa Ag Sheet-like material with hydrophilic and hydrophobic areas and their production
KR100907253B1 (en) * 2007-10-17 2009-07-10 한국전자통신연구원 Lab-On-A-Chip and Method of Driving the Same
US20090104635A1 (en) * 2007-10-19 2009-04-23 Tom Cheng Xu Fluorescent Dry Test Strip Biosensor
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
DE102008006225A1 (en) 2008-01-25 2009-07-30 Tesa Ag Biosensor and its production
DK2260300T3 (en) * 2008-03-07 2014-01-13 Advanced Microdevices Pvt Ltd Method and Device for Particle Removal and Preparation of Drops for Qualitative and Quantitative Bioassay
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
JP5642066B2 (en) 2008-06-06 2014-12-17 インテュイティ メディカル インコーポレイテッド Method and apparatus for performing an assay to determine the presence or concentration of an analyte contained in a sample of body fluid
WO2009148626A1 (en) 2008-06-06 2009-12-10 Intuity Medical, Inc. Medical diagnostic devices and methods
EP2145683A1 (en) * 2008-07-14 2010-01-20 F.Hoffmann-La Roche Ag Analytic test element with hydrophilic modified surface
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
CN102471796A (en) 2009-07-27 2012-05-23 舒尔传感器有限公司 Improvements relating to sensor devices
TWI428600B (en) * 2009-09-11 2014-03-01 Forward Electronics Co Ltd Microfluidic detection device and method for detecting molecules using the same
EP2506768B1 (en) 2009-11-30 2016-07-06 Intuity Medical, Inc. Calibration material delivery devices and methods
DE202010003766U1 (en) 2010-03-17 2010-08-19 Tesa Se Web-shaped material with high thickness precision
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US20120271123A1 (en) 2010-06-09 2012-10-25 Mark Castle Integrated lancing device
CA2803797A1 (en) 2010-06-25 2011-12-29 Intuity Medical, Inc. Analyte monitoring methods and systems
WO2013020103A1 (en) 2011-08-03 2013-02-07 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
JP2015508493A (en) * 2011-12-22 2015-03-19 ディーエスエム アイピー アセッツ ビー．ブイ． Use of multilayer fabric products as carriers for multilayer fabric products and dry matrix spot applications
JP2016522070A (en) 2013-06-21 2016-07-28 インテュイティ メディカル インコーポレイテッド Analyte monitoring system using audible feedback
CN106574929B (en) * 2014-07-25 2019-08-09 贝克顿·迪金森公司 Analyte testing item test and for its implement test-strips and kit

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292272A (en) * 1979-06-08 1981-09-29 Fuji Photo Film Co., Ltd. Multilayer analysis sheet for analyzing liquid samples
US4631174A (en) * 1978-05-02 1986-12-23 Fuji Photo Film Co., Ltd. Multilayer chemical analysis member having an outer waterproof layer
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5200148A (en) * 1988-01-11 1993-04-06 Fuji Photo Film Co., Ltd. Chemical assay tape
US5215712A (en) * 1989-09-14 1993-06-01 Terumo Kabushiki Kaisha Apparatus for determination of ion concentration, specific gravity, or osmotic pressure of solution
US5296192A (en) * 1992-04-03 1994-03-22 Home Diagnostics, Inc. Diagnostic test strip
US5310525A (en) * 1990-02-08 1994-05-10 Whatman Scientific Limited Fluid detection device
US5552276A (en) * 1993-03-18 1996-09-03 Mochida Pharmaceutical Co., Ltd. Apparatus and process for simplified measurement
US5709837A (en) * 1994-10-19 1998-01-20 Fuji Photo Film Co., Ltd. Dry analytical element containing ampholyte
US5827477A (en) * 1987-06-27 1998-10-27 Boeringer Mannheim Gmbh Process for the preparation of a diagnostic test carrier and the carrier thus produced
US5968836A (en) * 1992-05-12 1999-10-19 Lifescan, Inc. Fluid conducting test strip with transport medium
US6071251A (en) * 1996-12-06 2000-06-06 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631174A (en) * 1978-05-02 1986-12-23 Fuji Photo Film Co., Ltd. Multilayer chemical analysis member having an outer waterproof layer
US4292272A (en) * 1979-06-08 1981-09-29 Fuji Photo Film Co., Ltd. Multilayer analysis sheet for analyzing liquid samples
US5304468A (en) * 1986-08-13 1994-04-19 Lifescan, Inc. Reagent test strip and apparatus for determination of blood glucose
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5827477A (en) * 1987-06-27 1998-10-27 Boeringer Mannheim Gmbh Process for the preparation of a diagnostic test carrier and the carrier thus produced
US5200148A (en) * 1988-01-11 1993-04-06 Fuji Photo Film Co., Ltd. Chemical assay tape
US5215712A (en) * 1989-09-14 1993-06-01 Terumo Kabushiki Kaisha Apparatus for determination of ion concentration, specific gravity, or osmotic pressure of solution
US5310525A (en) * 1990-02-08 1994-05-10 Whatman Scientific Limited Fluid detection device
US5296192A (en) * 1992-04-03 1994-03-22 Home Diagnostics, Inc. Diagnostic test strip
US5968836A (en) * 1992-05-12 1999-10-19 Lifescan, Inc. Fluid conducting test strip with transport medium
US5552276A (en) * 1993-03-18 1996-09-03 Mochida Pharmaceutical Co., Ltd. Apparatus and process for simplified measurement
US5709837A (en) * 1994-10-19 1998-01-20 Fuji Photo Film Co., Ltd. Dry analytical element containing ampholyte
US6071251A (en) * 1996-12-06 2000-06-06 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858884B2 (en) 2013-03-15 2014-10-14 American Sterilizer Company Coupled enzyme-based method for electronic monitoring of biological indicator
US9121050B2 (en) 2013-03-15 2015-09-01 American Sterilizer Company Non-enzyme based detection method for electronic monitoring of biological indicator
WO2020137532A1 (en) * 2018-12-28 2020-07-02 テルモ株式会社 Test strip and component measurement system
JPWO2020137532A1 (en) * 2018-12-28 2021-11-11 テルモ株式会社 Test strip and component measurement system
JP7442461B2 (en) 2018-12-28 2024-03-04 テルモ株式会社 Component measurement system

Also Published As

Publication number Publication date
US6555061B1 (en) 2003-04-29
TWM263498U (en) 2005-05-01
MY134148A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
US6555061B1 (en) Multi-layer reagent test strip
EP0345781B1 (en) Defined volume test device
US4994238A (en) Constant volume chemical analysis test device
US5418142A (en) Glucose test strip for whole blood
KR100589871B1 (en) Visual blood glucose test strip
MXPA97002503A (en) Reagent test stress to determine glucose in the san
EP0819180A1 (en) Combined assay for current glucose level and intermediate or long-term glycemic control
US5470752A (en) Multi-layer devices and methods of assaying for fructosamine
EP0408223B1 (en) Device and method for separation of plasma from blood and determination of blood analytes
JPH02150751A (en) Implement and method for analyzing specific component in liquid sample
EP2438859B1 (en) Strip for measuring biodata and method for measuring biodata
EP0408222A1 (en) Device and method for separation of fluid components
JPH09127106A (en) Liquid sample analyzing tool and analyzing method
US5304467A (en) Device for assay of liquid sample
JPH05203655A (en) Device and method for biological analysis containing particle separation system
CN109580489A (en) The chip and method of blood glucose and blood lipid are detected simultaneously
US20110287461A1 (en) Enzymatic analytical membrane, test device and method
EP1159613B1 (en) Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer
EP0371503B1 (en) Device for assay of liquid sample
JPH01289495A (en) Alcohol analyzing element
WO2023162095A1 (en) Blood testing device
JPH02176565A (en) Multilayered analyzing element
JPH0989888A (en) Analyzing element conforming to whole blood
US8501111B2 (en) Small volume and fast acting optical analyte sensor
MXPA99007484A (en) Stress for visual test of glucose in the san

Legal Events

Date Code Title Description
AS Assignment

Owner name: LIFESCAN, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEONG, KOON-WAH;YU, YEUNG SIU;RICE, EDWARD GRAY;REEL/FRAME:014038/0326

Effective date: 20001005

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION